Dissertation
Dissertation > Medicine, health > Oncology > General issues > Tumor diagnostics

The Experiment and Clinic Research That Learns to Build Targeting Lipid-coated Ultrasound Contrast Agents as Diagnostic Tool to the Malignant Tumor

Author YeYongQiang
Tutor DongJiaHong
School Third Military Medical University
Course Surgery
Keywords Targeted ultrasound contrast agent Melanoma αvβ3 Radiofrequency ablation HCC
CLC R730.4
Type PhD thesis
Year 2005
Downloads 90
Quotes 0
Download Dissertation

Background: With CT, MRI and other imaging technology continues to progress, liver cancer diagnosis rate continues to improve, CT and MRI can be detected in about 1 ~ 2cm small liver cancer, but for smaller lesions are powerless. AFP and other laboratory tests can help in early diagnosis of liver cancer, but can not accurately locate lesions. Therefore, an urgent clinical need for an early diagnosis can, accurate positioning of the lesion can be simple and easy diagnostic method. Ultrasonography is the most commonly used clinical and convenient diagnostic techniques, such as second harmonic, such as intermittent ultrasound imaging ultrasound technologies, as well as fluorocarbon further maturation of ultrasound contrast agents, targeted acoustic imaging techniques gradually from the experimental into clinical applications for clinical meet the above requirements provided new diagnostic method has very important clinical significance, ultrasound molecular imaging diagnostic technology may cause a new revolution. Purpose: Angiogenesis is tumor progression, invasion and metastasis critical, this study from the tumor angiogenesis important intercellular adhesion molecule integrin start using targeted contrast echocardiography technology to improve the detection rate of liver tumors, early clinical provide the basis for the treatment of tumors in order to improve the treatment of liver cancer and prognosis. While applying commercial production, ultrasound contrast agents for clinical randomized controlled studies, summarized in the clinical diagnosis, monitoring and evaluation of cancer treatment and other aspects of the role in the diagnosis at the same time, combined with real-time monitoring of treatment and after treatment, to improve treatment. Methods: Preparation of contrast agent and the lipid Properties Evaluation: The distearoyl phosphatidyl choline (DSPC), dipalmitoyl phosphatidyl glycerol (DPPG), polyethylene glycol (PEG) was suspended in an aqueous solution by a certain percentage , the freeze-dried, add sugar solution and a surface active agent, shake well, back into suspension, pumping the air inside the container, adding perfluoro propane gas (C3F8), the resulting supernatant was discarded standing layered product , that is made necessary microbubbles. Using OLYMPUS BX50 (Olympus, Japan) microscope microscope lipid contrast agent 'Zhifuxian' microbubbles distribution, size, shape; using Sysmex KX-21 hematology analyzer measured the concentration of contrast agent microbubbles; Zeta SIZER 3000 measured potential PH value and surface potential. The combination of microbubble antibody method: microbubbles produced before adding carbodiimide 1.5mg, together with material made of microbubble suspension assembly, after mixing, followed by adding the nominal concentration of microbubbles with a red anti-αvβ3 antibody fluorescence, as the gas extraction vessel, adding perfluoro propane gas (C3F8), using sound vibration meter oscillator 45 seconds

Related Dissertations
More Dissertations